Intech Investment Management LLC Sells 2,094 Shares of STERIS plc $STE

Intech Investment Management LLC lessened its stake in STERIS plc (NYSE:STE) by 11.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,617 shares of the medical equipment provider’s stock after selling 2,094 shares during the quarter. Intech Investment Management LLC’s holdings in STERIS were worth $3,752,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC raised its holdings in STERIS by 42.1% in the 1st quarter. CWM LLC now owns 3,518 shares of the medical equipment provider’s stock worth $797,000 after acquiring an additional 1,042 shares during the last quarter. Victory Capital Management Inc. lifted its stake in STERIS by 3.7% during the 1st quarter. Victory Capital Management Inc. now owns 72,992 shares of the medical equipment provider’s stock valued at $16,544,000 after acquiring an additional 2,591 shares during the period. Teachers Retirement System of The State of Kentucky boosted its holdings in shares of STERIS by 2.7% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 7,605 shares of the medical equipment provider’s stock valued at $1,723,000 after acquiring an additional 199 shares during the last quarter. Allianz Asset Management GmbH grew its stake in shares of STERIS by 31.9% in the first quarter. Allianz Asset Management GmbH now owns 102,488 shares of the medical equipment provider’s stock worth $23,229,000 after acquiring an additional 24,809 shares during the period. Finally, Crestwood Advisors Group LLC purchased a new position in shares of STERIS during the first quarter valued at approximately $1,403,000. 94.69% of the stock is currently owned by institutional investors.

Insider Activity at STERIS

In other news, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the transaction, the vice president owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Daniel A. Carestio sold 159 shares of the firm’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $241.82, for a total value of $38,449.38. Following the completion of the sale, the chief executive officer owned 51,096 shares of the company’s stock, valued at approximately $12,356,034.72. This represents a 0.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.07% of the stock is owned by company insiders.

STERIS Price Performance

Shares of STERIS stock opened at $257.15 on Wednesday. The firm has a market cap of $25.24 billion, a PE ratio of 39.38 and a beta of 1.02. The stock has a 50 day moving average of $246.32 and a 200 day moving average of $240.93. The company has a current ratio of 2.22, a quick ratio of 1.53 and a debt-to-equity ratio of 0.27. STERIS plc has a 12 month low of $200.98 and a 12 month high of $268.30.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.During the same period in the prior year, the company earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, research analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be given a $0.63 dividend. The ex-dividend date is Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is currently 36.21%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Morgan Stanley raised their price target on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. KeyCorp boosted their target price on shares of STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a research report on Tuesday, July 22nd. Finally, Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $273.50.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.